Litcius/Paper detail

ERK-Smurf1-RhoA signaling is critical for TGFβ-drived EMT and tumor metastasis

Jianzhong Zheng, Zhiyuan Shi, Pengbo Yang, Yue Zhao, Wenbin Tang, Shaopei Ye, Zuodong Xuan, Chen Chen, Chen Shao, Qingang Wu, Huimin Sun

2022Life Science Alliance23 citationsDOIOpen Access PDF

Abstract

Epithelial-mesenchymal transition (EMT) has fundamental roles in various biological processes. However, there are still questions pending in this fast-moving field. Here we report that in TGFβ-induced EMT, ERK-mediated Smurf1 phosphorylation is a prerequisite step for RhoA degradation and the consequent mesenchymal state achievement. Upon TGFβ treatment, activated ERK phosphorylates Thr223 of Smurf1, a member of HECT family E3 ligase, to promote Smurf1-mediated polyubiquitination and degradation of RhoA, thereby leading to cell skeleton rearrangement and EMT. Blockade of phosphorylation of Smurf1 inhibits TGFβ-induced EMT, and accordingly, dramatically blocks lung metastasis of murine breast cancer in mice. Hence, our study reveals an unknown role of ERK in TGFβ-induced EMT and points out a potential strategy in therapeutic intervention.

Topics & Concepts

RHOAMAPK/ERK pathwayCancer researchUbiquitin ligasePhosphorylationEpithelial–mesenchymal transitionMetastasisTransforming growth factorSignal transductionChemistryCell biologyCancerUbiquitinBiologyMedicineInternal medicineBiochemistryGeneTGF-β signaling in diseasesCancer Cells and MetastasisCancer-related Molecular Pathways
ERK-Smurf1-RhoA signaling is critical for TGFβ-drived EMT and tumor metastasis | Litcius